Journal of Clinical Oncology (JCO) Podcast
Health

Journal of Clinical Oncology (JCO) Podcast

by American Society of Clinical Oncology (ASCO)

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice.
The JCO Podcast also features in depth summaries and interviews hosted by the year's fellows in the series, JCO Article Insights.

100 episodes
EN language
All Episodes
1
The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC
19:20 Mar 12, 2026
2
Atezolizumab, Bevacizumab, and Non-Platinum Chemotherapy for PROC
6:21 Feb 23, 2026
3
Ribociclib Plus Letrozole in Recurrent LGSOC: GOG 3026
6:41 Feb 23, 2026
4
NCI Working Group on Biochemically Recurrent Prostate Cancer
28:15 Feb 12, 2026
5
Association Between EOL SACT and Healthcare Utilization
23:00 Jan 8, 2026
6
Milan Consensus Endpoints for Bladder Preservation in MIBC
27:18 Dec 11, 2025
7
JCO at 2025 ASH: Pirtobrutinib in Untreated CLL
20:17 Dec 9, 2025
8
JCO at ASH 2025: A New Validated Staging System for AL Amyloidosis: AL-ISS
15:02 Dec 7, 2025
9
JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC
10:31 Nov 24, 2025
10
Health Outcomes in Older Childhood Cancer Survivors
21:22 Nov 20, 2025
11
Long-Term Remission After Cilta-cel in Patients With RRMM
27:31 Nov 13, 2025
12
JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN
8:25 Oct 27, 2025
13
Income Among Adolescents and Young Adults Surviving Cancer
16:16 Oct 9, 2025
14
JCO Article Insights: Phase I DLL3/CD3 T-Cell Engager in DLL3-Positive SCLC or NECs
12:51 Sep 29, 2025
15
TTFields in Locally Advanced Pancreatic Adenocarcinoma
18:42 Sep 11, 2025
16
JCO at WCLC: Multinational Pivotal Study of Sunvozertinib in Exon20ins NSCLC
7:45 Sep 9, 2025
17
Racial and Ethnic Disparities Among Medicare Beneficiaries
28:43 Aug 28, 2025
18
JCO Article Insights: Lymph Node Dissection for Lung Cancer
21:49 Aug 25, 2025
19
JCO Article Insights: IMS-IMWG Consensus on High-Risk Multiple Myeloma
24:50 Jul 28, 2025
20
JCO Article Insights: Pooled Taletrectinib Efficacy and Safety
15:02 Jun 30, 2025
21
JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC
6:54 Jun 2, 2025
22
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare
8:17 May 31, 2025
23
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC
8:42 May 31, 2025
24
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma
6:24 May 31, 2025
25
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer
6:52 May 31, 2025
26
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome
15:50 May 29, 2025
27
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases
23:59 May 8, 2025
28
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer
6:47 Apr 28, 2025
29
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment
26:50 Apr 10, 2025
30
JCO Article Insights: Smoking Assessment
8:35 Mar 31, 2025
31
Botensilimab Plus Balstilimab in Advanced Sarcomas
21:00 Mar 13, 2025
32
JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer
8:47 Feb 24, 2025
33
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer
12:12 Feb 13, 2025
34
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC
10:21 Jan 27, 2025
35
Air Pollution and Breast Cancer Incidence
25:43 Jan 9, 2025
36
JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing
9:01 Dec 30, 2024
37
Overcoming Barriers to Make Patient-Partnered Research a Reality
34:38 Dec 12, 2024
38
JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma
9:42 Nov 25, 2024
39
Quality of Treatment Selection
25:05 Nov 14, 2024
40
JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy
9:52 Oct 28, 2024
41
Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer
16:40 Oct 16, 2024
42
Combining Response and Toxicity Data to Implement Project Optimus
23:55 Sep 30, 2024
43
CBT-I for Cancer-Related Cognitive Impairment
31:21 Sep 12, 2024
44
JCO Article Insights: Assisted Reproduction in Breast Cancer Patients
22:48 Aug 26, 2024
45
Multi-Cancer Early Detection Testing for High-Risk Patients
30:29 Aug 8, 2024
46
JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade
17:27 Jul 29, 2024
47
Functional Disability Among US Cancer Survivors
16:12 Jul 11, 2024
48
CAR T-Cell Therapy for Richter's Transformation
9:19 Jun 24, 2024
49
EAZ171: Predictors of TIPN in Black Women with Breast Cancer
14:38 Jun 3, 2024
50
JCO Article Insights: Final Analysis of the Ro-CHOP Trial
8:49 May 27, 2024
Select an episode
0:00 0:00